axe

No data found

Search axe biology news at Google

Search axe biology news at Yahoo

Search axe biology news at Msn

axe at Biology Products

dotLab System, Dual Pump from Axela Biosensors

Description:The dotLab System brings together two mature, well-understood technologies: grating-based light diffraction and immobilized capture surfaces. This combination produces a sensitive and very simple technique for the detection of molecular binding events without the use of fluorescent labels. Protein-specific capture molecules are immobilized on the dotLab Sensor surface in eight distinct l...
Company:Axela Biosensors

dotLab System, Single Pump from Axela Biosensors

Description:The dotLab System brings together two mature, well-understood technologies: grating-based light diffraction and immobilized capture surfaces. This combination produces a sensitive and very simple technique for the detection of molecular binding events without the use of fluorescent labels. Protein-specific capture molecules are immobilized on the dotLab Sensor surface in eight distinct l...
Company:Axela Biosensors

axe at Biology Technology

Early Stage: Step 6 - Taxes, taxes, taxes!

- Now you have formed an entity. As part of the decision as to the type of entity to use, you should have concerned yourself with taxes...

A Screen of shRNAs Targeting Tumor Suppressor Genes to Identify Factors Involved in Paclitaxel Sensitivity

Diana Ji, Stacy L. Deeds, and Edward J. Weinstein RNA interference methodologies have been utilized in small to large scale screening projects. The technology has allowed researchers to perform gene-silencing experiments in timeframes and target cells previously not possible. While siRNA screens have become fairly common, large scale screening wi...

Healthcare of business: Universal coverage plan includes new business taxes

Following the lead of California and Massachusetts, Illinois has called he...

High taxes and low rates of entrepreneurship - is there a relationship?

Holding down taxes? That...

In public attitudes about taxes and spending, Wisconsin is Jekyll and Hyde

For all the talk-show chatter about cutting government spending and holding the line on taxes in Wisconsin, do state policymakers or the people they represent really want to bite the bullet? Based on what happened last week in the Wisconsin Assembly, and what is likely to happen this week in the state Senate, the answer is a tepid "maybe." Perhaps ambivalence in the Capitol accu...

More>>

axe at Biology Dictionary

Relaxed DNA

into a new <a href="/ ?q=/ Biology-Dictionary/ nucleic_acid" class=...

axe at Medicine News

Emergency Services To Face The Axe

Patients are put to unnecessary risk due to shortage of staff at the accident and emergency units, doctors warn.// The cutting down of staff in the casualty departments is a move to bail the NHS out of its monetary predicament, claims the British Association for Emergency Medicine (BAEM). Last year, Bristol's South Mead Hospital was converted into a minor injuries unit and...

Vaccines, tobacco taxes and condoms in disease control

Information on the Disease Control Priorities project that plans the top health investments for disease control in developing countries // was given to health ministers from the Americas at the Pan American Health Organization Directing Council. According to the Pan American Health Organization, vaccines, taxes on tobacco and condom distribution are some of the "best buys" in health i...

Will The Combination Of Calcitriol and Docetaxel Work ?

Researchers from Canada, United States and Europe are registering men with advanced prostate cancer //for a study involving a treatment that combines chemotherapy with high-dose of Calcitriol, a naturally occurring active form of vitamin D. This clinical trial will test whether specially formulated high-dose vitamin D, taken in combination with a chemotherapy drug called Docetaxel, inc...

Smokers to Be Taxed to Fund Healthcare for Uninsured

In a double blow for health, Indiana legislators in the US have decided on raising tax on cigarettes and channelizing the additional earnings towards healthcare. // As per a deal agreed upon on Sunday, the state's cigarette tax would be hiked by 44 cents per pack and the expected additional flow to the treasury, of the order of 200 million dollars a year would help fund several health...

Hair Relaxers Not Linked With Breast Cancer Risk

A new study has found that chemical relaxers used to straighten hair are not associated with an increased risk of developing breast cancer among African-American women. Hair relaxers can enter the body through cuts or lesions in the scalp. These products are not fully monitored by the Food and Drug Administration, and thus could contain potentially harmful compounds....

axe at Medicine Products

AXel 300

Description:Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Company:B. Braun Medical Inc.

AXel 180

Description:Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Company:B. Braun Medical Inc.

TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System

Description:The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter....
Company:Boston Scientific Corporation

TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System

Description:The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter....
Company:Boston Scientific Corporation

Maxenon Xi 300

Description:Ideal for use with our High Beam headlight. Rotating Turret allows use with other manufacturer's cables. Infinite intensity control. Excellent color definition (6000 K Color Temperature)....
Company:BFW, Inc.

More>>

axe at Medicine Technology

New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel

22 US Oncology Affiliated Physicians Participate in ASCOProceedings HOUSTON, June 04, 2007 /PRNewswire/ -- A leading cancerresearcher affiliated with the US Oncology Research Networkpresented findings from a randomized, multicenter phase III trialthat compared the disease-free survival (DFS) obtained with tworegimens of adjuvant therapy for patients with high-risk breastcancer. Th...

Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

ASCO Oral Presentation Reports Significantly More Patients Treatedwith Taxotere(R)-Based Chemotherapy Regimen Survived at Least ThreeYears CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Taxotere(R)(docetaxel) Injection Concentrate-based chemotherapy (Taxotere plusprednisone) maintained long-term efficacy as a treatment foradvanced (metastatic) hormone-resistant prostate cancer patients,...

Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

VIENNA, Austria, May 23, 2007-The chemotherapy drugdocetaxel currently offers the best treatment forandrogen-independent prostate cancer. That is the result of a nowpublished clinical trial that compared the efficacy of the two mostwidely used chemotherapy drugs. When using docetaxel, the risk ofdisease progression was cut by more than 50% than when using thenext-best chemotherapy drug.<...

Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years

Trial results report no new stent thrombosis after two years inhigh-risk patient population NATICK, Mass., and BARCELONA, Spain, May 22, 2007/PRNewswire-FirstCall/ -- Boston Scientific Corporation todayannounced four-year follow-up data from its TAXUS VI clinicaltrial. The data demonstrated that the safety and efficacy benefitsassociated with a moderate-release formulation of the TAXUS(R)...

Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh to be Presented at European Vascular Symposium

STRASBOURG, France and VANCOUVER, April 26, 2007/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , a globalspecialty pharmaceutical and medical device company, announced thatthe two-year data from its European pivotal trial examining theVascular Wrap(TM) Paclitaxel-Eluting Mesh ("Vascular Wrap(TM)")will be presented today at a scientific forum in Europe. Thetwo-year study examine...

More>>